Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

437.15 +2.63 (+0.61%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

68 69 Next >

VRTX Stock Earnings: Vertex Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

VRTX stock results show that Vertex Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Vertex Pharmaceuticals (VRTX) Q1 2024 Earnings Call Transcript ↗

May 06, 2024

VRTX earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Vertex Beats First-Quarter Expectations, But Shares Stay Flat On Reiterated Outlook ↗

May 06, 2024

Vertex Pharmaceuticals beat first-quarter sales and earnings forecasts.

Via Investor's Business Daily

Vertex Reports First Quarter 2024 Financial Results

May 06, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 Biotech Stocks to Double Your Money in the Next 24 Months ↗

May 06, 2024

The biotech sector offers significant potential for growth. These 3 biotech stocks to double your money are noteworthy candidates.

Via InvestorPlace

Smart Money Is Betting Big In VRTX Options ↗

May 06, 2024

Via Benzinga

(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest ↗

April 25, 2024

Via Benzinga

2 Fantastic Growth Stocks to Buy Right Now ↗

April 25, 2024

Don't overlook these high-growth businesses.

Via The Motley Fool

3 No-Brainer Stocks to Buy in May ↗

May 05, 2024

These great stocks are great picks for investors as spring winds down.

Via The Motley Fool

3 Biotech Stocks With the Potential to Make You an Overnight Millionaire ↗

May 04, 2024

Don’t miss out on these stocks that could rock your portfolio with massive growth following FDA approvals and breakthrough treatments.

Via InvestorPlace

A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation ↗

May 03, 2024

Earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation report.

Via Investor's Business Daily

Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar ↗

May 03, 2024

The gene editing stocks are worth tuning into as some investors out there discount their innovative, albeit early-stage pipelines.

Via InvestorPlace

3 Growth Stocks You’ll Kick Yourself for Not Buying Today ↗

May 03, 2024

Netflix, Intuit, and Vertex Pharmaceuticals are three growth stocks to buy, each positioned for significant market share and returns.

Via InvestorPlace

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar ↗

May 03, 2024

Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.

Via InvestorPlace

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years ↗

May 02, 2024

Via Benzinga

2 Top Growth Stocks to Buy Right Now and Hold Forever ↗

April 28, 2024

These healthcare stocks can provide enviable long-term portfolio growth.

Via The Motley Fool

Want $1 Million in Retirement? 3 Stocks to Buy Now And Hold for Decades. ↗

April 27, 2024

These three should have a lot of room to run.

Via The Motley Fool

$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs ↗

April 26, 2024

Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.

Via Benzinga

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

April 24, 2024

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

Via The Motley Fool

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? ↗

April 23, 2024

Vertex is broadening its portfolio.

Via The Motley Fool

Making Sense of Amazon CEO Andy Jassy's Latest Letter ↗

April 22, 2024

And that's just part of the interesting news for investors to dig into.

Via The Motley Fool

If You'd Invested $10,000 in Vertex Pharmaceuticals 5 Years Ago, Here's How Much You'd Have Today ↗

April 22, 2024

Could Vertex's growth story continue?

Via The Motley Fool

Looking for Once-in-a-Generation Investment Opportunities? Here Are 3 Magnificent Stocks to Buy Right Now ↗

April 22, 2024

These stocks could be near major inflection points.

Via The Motley Fool

2 Everlasting Big Pharma Stocks to Buy Today and Hold Forever ↗

April 20, 2024

These stocks probably won't be getting much cheaper.

Via The Motley Fool

3 Relatively Safe Growth Stocks You Can Buy and Hold ↗

April 20, 2024

Low risk and high-reward potential? These stocks could offer both.

Via The Motley Fool

3 Biotech Stocks Set to Double by 2028 ↗

April 20, 2024

These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.

Via InvestorPlace

Is Vertex Pharmaceuticals Stock a Millionaire Maker? ↗

April 19, 2024

Does this pharma stock have the potential to turn a $25,000 investment into seven figures or more?

Via The Motley Fool

Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday ↗

April 18, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy? ↗

April 18, 2024

The biotech just added another potential growth driver to its pipeline.

Via The Motley Fool

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

April 18, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vertex Pharmaceuticals (NQ:VRTX)

All News about Vertex Pharmaceuticals

Starting at $3.75/week.

Subscribe Today